Incyte, Novartis to test repurposed cancer drug in COVID-19
The drugmakers, which are partnered on Incyte's therapy Jakafi, plan to quickly start Phase 3 trials in patients with inflammatory responses tied to COVID-19.

Apr 10, 2020 0 27
Mar 6, 2020 0 21
Mar 25, 2020 0 18
Mar 17, 2020 0 16
Mar 13, 2020 0 15
Mar 13, 2020 0 403
Mar 3, 2020 0 168
Senti Biosciences has named Jose Iglesias as its chief medical officer. Iglesias...
May 20, 2020 0 128
Genfit warns costs of failed NASH trial will drag deep into 2020 ntaylor Tue, 05/19/2020...
Apr 30, 2020 0 141
Credit: Luca Carena/The University of Torino According to a study published in Water...
May 13, 2020 0 147
UC Riverside-led study identifies role played by an immune signaling molecule in...
Apr 21, 2020 0 132
A combination of Opdivo with Exelixis' Cabometyx, if cleared for use, would compete...
May 13, 2020 0 148
Four companies are close to human tests of antibody drugs that could help treat,...
Apr 16, 2020 0 136
Credit: Temple University Health System Temple University Hospital has treated the...
Mar 24, 2020 0 192
Today, we are continuing our interview series with Peter Homberg, Partner and Head...
Apr 21, 2020 0 211
The biotech's employees, who were some of the first people in Massachusetts diagnosed...